1 comment By Julie Grisham, MS, Science Writer/Editor | Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. read more
5 comments By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, May 20, 2014 With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.
Add a Comment By Media Staff | Thursday, May 15, 2014 New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.
Add a Comment By Julie Grisham, MS, Science Writer/Editor | Tuesday, May 27, 2014 David Solit , Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology , discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.
Add a Comment By Maureen Salamon, BA, Freelance Writer | Monday, May 19, 2014 Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.
3 comments By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 19, 2014 Cancer treatments, both traditional treatments and newer targeted therapies, can lead to short-term and long-term heart problems. read more